Patient characteristics and observations for contrast-enhanced magnetic resonance angiography and digital subtraction angiography
| Patient No./Sex/Age (y) | CE-MRA | DSA | Pathology | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| AKA | Other | GARV | AKA | Other | GARV | |||||
| Level | Side | ARA | Level | Side | Level | Side | ARA | |||
| 1/M/44 | T9 | Right | No | L2 | Right | T9 | Right | T4 | No | Hemangioblastoma |
| 2/M/62 | T8 | Left | No | L3 | Right | T8 | Left | No | No | SDAVF |
| 3/M/57 | L1 | Right | No | No | No | L1 | Right | No | No | SAVM, fistulous type |
| 4/M/63 | T9 | Left | No | L1 | Right | T9 | Left | No | No | Spinal SAH |
| 5/M/73 | T12 | Left | No | L3 | Right | T12 | Left | T3 | No | None |
| 6/M/64 | T12 | Left | No | L2 | Left | T12 | Left | No | No | SDAVF |
| 7/M/48 | T11 | Left | No | L3 | Right | T11 | Left | No | No | SDAVF |
| 8/M/55 | L1 | Right | No | L3 | Right | L1 | Right | No | No | SDAVF |
| 9/M/72 | T11 | Left | No | L2 | Right | T11 | Left | No | No | SDAVF |
| 10/M/66 | L2 | Left | No | L2 | Right | L2 | Left | No | No | SDAVF |
| 11/F/43 | T12 | Left | No | No | No | L1 | Left | No | No | SAVM, fistulous type |
| 12/F/43 | T11 | Right | No | L3 | Left | T11 | Right | No | No | None |
| 13/M/73 | T10 | Left | No | L2 | Right | T10 | Left | No | No | SDAVF |
| 14/F/76 | T12 | Right | No | L3 | Right | T12 | Right | No | No | SDAVF |
| 15/M/59 | L1 | Left | No | L2 | Right | L1 | Left | No | No | None |
Note:—CE-MRA indicates contrast-enhanced magnetic resonance angiography; DSA, digital subtraction angiography; AKA, Adamkiewicz artery; ARA, anterior radiculomedullary artery; GARV, great anterior radiculomedullary vein; T, thoracic; L, lumbar; SDAVF, spinal dural anteriovenous fistula; SAVM, spinal arteriovenous malformation; SAH, subarachnoidal hemorrhage. For a description of the present spinal vascular pathology, we refer to the existing literature.30